|
Montenegro MF, Sáez-Ayala M, Piñero-Madrona A, Cabezas-Herrera J, Rodríguez-López JN. Reactivation of the tumour suppressor RASSF1A in breast cancer by simultaneous targeting of DNA and E2F1 methylation. PLoS One. 2012;7(12):e52231. doi: 10.1371/journal.pone.0052231. Epub 2012 Dec 14. PubMed PMID: 23251702; PubMed Central PMCID: PMC3522638.
AÑO: 2012; IF: 2.74
|
23251702
|
Sáez-Ayala M, Fernández-Pérez MP, Montenegro MF, Sánchez-del-Campo L, Chazarra S, Piñero-Madrona A, Cabezas-Herrera J, Rodríguez-López JN. Melanoma coordinates general and cell-specific mechanisms to promote methotrexate resistance. Exp Cell Res. 2012 Jun 10;318(10):1146-59. doi: 10.1016/j.yexcr.2012.03.022. Epub 2012 Mar 29. PubMed PMID: 22484375.
AÑO: 2012; IF: 3.383
|
|
Sáez-Ayala M, Sánchez-del-Campo L, Montenegro MF, Chazarra S, Tárraga A, Cabezas-Herrera J, Rodríguez-López JN. Comparison of a pair of synthetic tea-catechin-derived epimers: synthesis, antifolate activity, and tyrosinase-mediated activation in melanoma. ChemMedChem. 2011 Mar 7;6(3):440-9. doi: 10.1002/cmdc.201000482. Epub 2011 Feb 7. PubMed PMID: 21302360.
AÑO: 2011; IF: 3.151
|
|
Fernández-Gómez FJ, Muñoz-Delgado E, Montenegro MF, Campoy FJ, Vidal CJ, Jordán J. Cholinesterase activity in brain of senescence-accelerated-resistant mouse SAMR1 and its variation in brain of senescence-accelerated-prone mouse SAMP8. J Neurosci Res. 2010 Jan;88(1):155-66. doi: 10.1002/jnr.22177. PubMed PMID: 19610099.
AÑO: 2010; IF: 2.958
|
|
Sánchez-del-Campo L, Chazarra S, Montenegro MF, Cabezas-Herrera J, Rodríguez-López JN. Mechanism of dihydrofolate reductase downregulation in melanoma by 3-O-(3,4,5-trimethoxybenzoyl)-(-)-epicatechin. J Cell Biochem. 2010 Aug 15;110(6):1399-409. doi: 10.1002/jcb.22656. PubMed PMID: 20564235.
AÑO: 2010; IF: 3.122
|